ORKA

Oruka Therapeutics, Inc. Common Stock

19 hedge funds and large institutions have $16.3M invested in Oruka Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NMC
1
NEA Management Company
Maryland
$4.16M 1,460,209
Franklin Resources
2
Franklin Resources
California
$3.47M 1,216,840
VMI
3
VHCP Management II
New York
$3.08M 1,078,932
TCM
4
Tekla Capital Management
Massachusetts
$2.31M 811,227
VM
5
VHCP Management
New York
$1.32M 462,399
RCM
6
RA Capital Management
Massachusetts
$662K 232,245 -289,361 -55%
ACP
7
Aveo Capital Partners
Colorado
$661K 231,775 +231,775 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$347K 121,657
Deutsche Bank
9
Deutsche Bank
Germany
$131K 46,111 +8,400 +22%
Goldman Sachs
10
Goldman Sachs
New York
$58K 20,326 -1,672 -8%
Renaissance Technologies
11
Renaissance Technologies
New York
$55K 19,184 +19,184 New
BFA
12
BlackRock Fund Advisors
California
$43K 14,998 +142 +1%
Cambridge Investment Research Advisors
13
Cambridge Investment Research Advisors
Iowa
$30K 10,452
BIM
14
BlackRock Investment Management
Delaware
$3K 1,046
UBS Group
15
UBS Group
Switzerland
$3K 1,012 +985 +3,648%
Bank of America
16
Bank of America
North Carolina
$2K 576 -2,320 -80%
RA
17
Royce & Associates
New York
-125,733 Closed
Millennium Management
18
Millennium Management
New York
-10,663 Closed
TRCT
19
Tower Research Capital (TRC)
New York
-517 Closed
Creative Planning
20
Creative Planning
Kansas
$0 9 -140 -94%
SPIA
21
Steward Partners Investment Advisory
New York
$0 1 +1 New
Morgan Stanley
22
Morgan Stanley
New York
$0 2 +2 New